To cite this paper use one of the standards below:
Low-level laser therapy (LLLT) is a non-invasive approach capable of promoting molecular, cellular, and systemic effects, such as ATP synthesis, proliferation, and wound healing. However, in cancer, there is debate regarding its safety due to its potential to stimulate cell proliferation. Breast cancer is the leading cause of cancer in women worldwide, and p53 mutations play a central role in tumor progression, especially mutations in the DNA-binding domain, which lead to loss of function, dominant-negative effects, and amyloid-like aggregates with prion-like properties. While LLLT has been studied for reducing amyloidogenic proteins in neurodegenerative diseases, its effects on protein aggregation in cancer remain unexplored. This study aimed to evaluate the effects of low-power infrared laser (808 nm; 20 and 200 J/cm²) on p53 aggregation in MDA-MB-231 breast cancer cells. Cells were irradiated and incubated for 24 and 48 hours, with non-irradiated cells as controls. Protein aggregation was assessed by dot blot and western blot, while p53 localization was analyzed by immunofluorescence. Cell viability and PRIMA1 drug sensitivity was measured by LDH release. Preliminary results suggest that infrared LLLT does not alter the quantity of p53 by dot blot and western blot assays, or modulate the nuclear aggregates localization of mutant p53 R280K at either fluence or time point. Additionally, no changes in cell viability and PRIMA1 drug sensitivity were observed. These findings indicate that low-power infrared laser does not modulate p53 aggregation or affect cell viability in MDA-MB-231 cells, although further studies are needed to clarify its effects on protein aggregation, gene expression, and cellular behavior.
This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnológico (CNPq), Coordenação de Aperfeiçoamento de Pessoal de nível superior (CAPES), and Fundação de Amparo à Pesquisa do Rio de janeiro (FAPERJ).
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper